These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3104711)

  • 21. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.
    Behre HM; Klein B; Steinmeyer E; McGregor GP; Voigt K; Nieschlag E
    J Clin Endocrinol Metab; 1992 Aug; 75(2):393-8. PubMed ID: 1639941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.
    Jungwirth A; Pinski J; Galvan G; Halmos G; Szepeshazi K; Cai RZ; Groot K; Vadillo-Buenfil M; Schally AV
    Eur J Cancer; 1997 Jun; 33(7):1141-8. PubMed ID: 9376196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).
    van Steenbrugge GJ; Romijn JC; de Jong FH; Schröder FH
    Urol Res; 1984; 12(3):175-8. PubMed ID: 6237478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.
    Séguin C; Cusan L; Bélanger A; Kelly PA; Labrie F; Raynaud JP
    Mol Cell Endocrinol; 1981 Jan; 21(1):37-41. PubMed ID: 6259002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1459-62. PubMed ID: 6219395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic D-Leu6, des-Gly10-gonadotropin releasing hormone ethylamide on male sex tissues.
    Rajfer J; Heber D; Peng S; Swerdloff RS
    Biol Reprod; 1984 Apr; 30(3):646-51. PubMed ID: 6426536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rapid effects of luteinizing hormone releasing hormone agonists and antagonists on the mouse pituitary in vitro.
    Kato K; Sairam MR
    Life Sci; 1983 Jan; 32(3):263-70. PubMed ID: 6401836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect inhibition of ovulation in rats by an antagonist of luteinizing hormone-releasing hormone.
    Nekola MV; Coy DH
    Endocrinology; 1985 Feb; 116(2):756-60. PubMed ID: 3917910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of a potent LHRH antagonist (Org 30850) in female and male rats.
    Deckers GH; de Graaf JH; Kloosterboer HJ; Loozen HJ
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):705-12. PubMed ID: 1504009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts.
    Oduwole OO; Poliandri A; Okolo A; Rawson P; Doroszko M; Chrusciel M; Rahman NA; Serrano de Almeida G; Bevan CL; Koechling W; Huhtaniemi IT
    FASEB J; 2021 Apr; 35(4):e21464. PubMed ID: 33724574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.
    Schally AV; Redding TW; Comaru-Schally AM
    Med Oncol Tumor Pharmacother; 1984; 1(2):109-18. PubMed ID: 6242477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of chemical castration in male rats by a new long-acting LHRH-antagonist.
    Habenicht UF; Schneider MR; el Etreby MF
    Prostate; 1990; 17(1):69-83. PubMed ID: 2201007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postcastration rise in plasma gonadotropins is blocked by a luteinizing hormone-releasing hormone antagonist.
    Condon TP; Sawyer CH; Heber D; Stewart JM; Whitmoyer DI
    Biol Reprod; 1985 Oct; 33(3):715-21. PubMed ID: 3931713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged inhibition of luteinizing hormone and testosterone levels in male rats with the luteinizing hormone-releasing hormone antagonist SB-75.
    Bokser L; Bajusz S; Groot K; Schally AV
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7100-4. PubMed ID: 2205853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.
    Faure N; Labrie F; Belanger A; Lemay A; Raynaud JP; Von der Ohe M; Fazekas AT
    J Endocrinol Invest; 1982; 5(6):355-60. PubMed ID: 6820372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH.
    Schally AV; Redding TW; Comaru-Schally AM
    Prostate; 1983; 4(6):545-52. PubMed ID: 6226942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.